NJ State Employees Deferred Compensation Plan’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-195,125
Closed -$517K 132
2025
Q3
$517K Hold
195,125
0.06% 282
2025
Q2
$192K Hold
195,125
0.02% 402
2025
Q1
$281K Hold
195,125
0.04% 365
2024
Q4
$429K Hold
195,125
0.05% 318
2024
Q3
$322K Hold
195,125
0.04% 360
2024
Q2
$433K Hold
195,125
0.05% 309
2024
Q1
$523K Hold
195,125
0.07% 277
2023
Q4
$583K Hold
195,125
0.08% 255
2023
Q3
$191K Hold
195,125
0.03% 432
2023
Q2
$271K Hold
195,125
0.04% 390
2023
Q1
$310K Buy
195,125
+185,000
+1,827% +$955K 0.05% 369
2022
Q4
$63.1K Hold
10,125
0.01% 469
2022
Q3
$68K Hold
10,125
0.01% 462
2022
Q2
$65K Hold
10,125
0.01% 463
2022
Q1
$47K Hold
10,125
0.01% 493
2021
Q4
$51K Hold
10,125
0.01% 496
2021
Q3
$122K Hold
10,125
0.02% 490
2021
Q2
$214K Hold
10,125
0.03% 476
2021
Q1
$284K Hold
10,125
0.04% 414
2020
Q4
$263K Hold
10,125
0.04% 406
2020
Q3
$376K Hold
10,125
0.07% 271
2020
Q2
$519K Hold
10,125
0.1% 209
2020
Q1
$320K Hold
10,125
0.07% 268
2019
Q4
$603K Hold
10,125
0.1% 217
2019
Q3
$372K Hold
10,125
0.07% 327
2019
Q2
$471K Hold
10,125
0.08% 285
2019
Q1
$406K Hold
10,125
0.07% 336
2018
Q4
$466K Sell
10,125
-1,000
-9% -$48.2K 0.1% 240
2018
Q3
$494K Sell
11,125
-4,000
-26% -$184K 0.08% 320
2018
Q2
$592K Buy
15,125
+4,000
+36% +$202K 0.11% 258
2018
Q1
$805K Sell
11,125
-2,000
-15% -$147K 0.14% 196
2017
Q4
$864K Hold
13,125
0.15% 189
2017
Q3
$658K Buy
+13,125
New +$633K 0.12% 262

Other funds holding ESPR